# Methotrexate in Metastatic Colorectal Cancer With MSH2 Deficiency

> **NCT00952016** · PHASE2 · TERMINATED · sponsor: **Royal Marsden NHS Foundation Trust** · enrollment: 2 (actual)

## Conditions studied

- Advanced Colorectal Cancer

## Interventions

- **DRUG:** Methotrexate

## Key facts

- **NCT ID:** NCT00952016
- **Lead sponsor:** Royal Marsden NHS Foundation Trust
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-02
- **Primary completion:** 2014-09
- **Final completion:** 2014-09
- **Target enrollment:** 2 (ACTUAL)
- **Why stopped:** Lack of recruitment - only 2 patients recruited.
- **Last updated:** 2016-10-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00952016

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00952016, "Methotrexate in Metastatic Colorectal Cancer With MSH2 Deficiency". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00952016. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*